Major companies in the market are focused on various business strategies such as gaining product approval from regulatory authorities, in order to expand their product portfolio and gain competitive edge in the market. For instance, in January 2019, Becton, Dickson and Company, a medical technology company, received the U.S. Food and Drug Administration 510(k) clearance for its second generation BD Nano pend needle, which is designed for reliable subcutaneous injection depth.
Major companies in the market are focused on various business strategies such as gaining product approval from regulatory authorities, in order to expand their product portfolio. For instance, in April 2019, B. Braun, a Germany-based pharmaceutical company, launched its Heparin Sodium Injection, which is a prefilled syringe for subcutaneous and intravenous use.